The latest anti-neocoronavirus drugs are Chikinden, Ritonavir tablets, Ambavizumab/Romivizumab injection, etc. 1. Chikindin has just been awarded the national invention patent, and the patent specification shows that 10μM of chikindin can inhibit the replication of coronavirus 15,393 times, and the ability of this drug to inhibit neocoronavirus is ranked the top among all the neocoronavirus inhibitors discovered by human beings. However, this class has not yet been approved for marketing and cannot be used in the clinic, while its effect for in vivo use, mechanism of action of anti-neocoronavirus, efficacy, safety and pharmacokinetics are unknown for the time being. 2.PF-07321332/Ritonavir Tablets (Paxlovid): For adults and adolescents with mild and common forms with high risk factors for progression to severe forms within 5 days of the onset of disease.14 It should not be used in combination with drugs such as pethidine, ranolazine, etc., which are highly dependent on CYP3A for clearance and whose increased plasma concentrations can lead to serious and/or life-threatening adverse reactions. 3. Ambavizumab/Romivizumab Injection: The combination is indicated for the treatment of adult and adolescent patients with mild and common forms of the disease with high risk factors for progression to severe forms. There are many other drugs in the preclinical research stage. The diagnosis of a new crown should be immediately reported to the local area and receive isolation treatment to avoid serious consequences.